On-demand printer for vaccines and therapeutics anywhere in the world
Revolutionizing vaccine production and distribution
Halting future pandemics with rapid response
Codex DNA aims to transform public health by enabling a new approach to producing vaccines, therapeutics, and diagnostics. Based on our world-leading automated synthesis technology, we are building a self-contained platform that can print life-saving treatments, starting only from information delivered digitally. We call it the Digital-to-biological converter (DBC) platform.
The DBC approach is revolutionary. Pre-stocked with reagents needed to synthesize genetic material — including DNA, RNA, and proteins, the system will take digitized DNA code sent over the internet, and automatically print and assemble vaccines. The entire process is expected to produce more than 500 vaccine doses within 48 hours, a drastic improvement over the six to nine months required today.
Establishing a global network of vaccine printers
Bypassing the challenges of production and distribution
By activating a global network of DBC platforms, it will be possible to dramatically accelerate the development and delivery of “on-demand” vaccines anywhere in the world, ultimately allowing rapid responses to disease outbreaks. The instantaneous electronic exchange of sequence data — followed by local gene synthesis and vaccine production — will replace the cumbersome isolation and shipment of viruses and nucleic acids between geographically dispersed sites where vaccines are manufactured. Also, by stocking platforms with all of the materials needed for vaccine synthesis, the DBC network will overcome many of the supply chain challenges that have emerged in the COVID-19 pandemic.
TED talk with our CTO
2018 TED talk with Dan Gibson, PhD
Dan Gibson, PhD, our Chief Technology Officer, introduces the world’s first and only automated platform for personalized medicine and distributed vaccine manufacturing at TED 2018.
Building a vaccine ready for distribution
The DBC platform will receive digitized DNA code and convert it into over 500 vaccine doses within 48 hours
Remove distribution-ready vaccine vials from DBC
The BioXp™ 3250 system
Accelerating the development of critical new vaccines and biologics
At the core of the DBC is the BioXp™ 3250 system, the world’s only fully automated synthetic biology workstation, which already performs most of the steps required to print vaccines and is paving the way for a global solution to prevent future pandemics.